Castelnovo G, et al. Long-term effectiveness, safety and tolerability with fingolimod treatment in patients with multiple sclerosis in real-world treatment settings in France: final results of the VIRGILE study. Poster 1388. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Effect van evobrutinib op ‘slowly expanding lesion’-volume bij relapsing MS
apr 2024 | Multipele Sclerose